Symbols / SHC Stock $15.27 -1.42% Sotera Health Company

Healthcare • Diagnostics & Research • United States • NMS
SHC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Mr. Michael B. Petras Jr.
Exch · Country NMS · United States
Market Cap 4.35B
Enterprise Value 6.31B
Income 117.79M
Sales 1.19B
FCF (ttm) 144.78M
Book/sh 2.13
Cash/sh 1.10
Employees 3,000
Insider 10d —
IPO Nov 20, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 37.24
Forward P/E 14.42
PEG 1.31
P/S 3.66
P/B 7.17
P/C —
EV/EBITDA 11.27
EV/Sales 5.31
Quick Ratio 2.36
Current Ratio 2.82
Debt/Eq 364.72
LT Debt/Eq —
EPS (ttm) 0.41
EPS next Y 1.06
EPS Growth —
Revenue Growth 10.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-05
ROA 8.51%
ROE 22.73%
ROIC —
Gross Margin 55.26%
Oper. Margin 31.26%
Profit Margin 9.91%
Shs Outstand 285.17M
Shs Float 192.25M
Insider Own 2.32%
Instit Own 91.34%
Short Float 5.77%
Short Ratio 5.26
Short Interest 14.25M
52W High 19.85
vs 52W High -23.07%
52W Low 10.79
vs 52W Low 41.45%
Beta 1.82
Impl. Vol. 29.58%
Rel Volume 2.01
Avg Volume 3.42M
Volume 6.86M
Target (mean) $20.12
Tgt Median $19.50
Tgt Low $16.00
Tgt High $24.00
# Analysts 8
Recom Buy
Prev Close $15.49
Price $15.27
Change -1.42%
About

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$20.13
Mean price target
2. Current target
$15.27
Latest analyst target
3. DCF / Fair value
$9.14
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$15.27
Low
$16.00
High
$24.00
Mean
$20.13

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-06 reit Piper Sandler Overweight → Overweight $22
2026-04-14 main Barclays Overweight → Overweight $18
2026-02-24 main Citigroup Buy → Buy $23
2026-01-09 up Piper Sandler Neutral → Overweight $24
2025-12-18 init William Blair — → Outperform —
2025-11-13 init BMO Capital — → Outperform $19
2025-11-05 main JP Morgan Neutral → Neutral $16
2025-11-05 main Barclays Overweight → Overweight $20
2025-11-05 main Piper Sandler Neutral → Neutral $17
2025-10-02 main Barclays Overweight → Overweight $19
2025-06-24 main Barclays Overweight → Overweight $13
2025-05-05 up Goldman Sachs Neutral → Buy $17
2025-04-23 main Piper Sandler Neutral → Neutral $13
2025-04-10 main Barclays Overweight → Overweight $12
2025-02-28 main Barclays Overweight → Overweight $16
2025-02-18 main Barclays Overweight → Overweight $17
2024-11-21 reit RBC Capital Outperform → Outperform $17
2024-11-06 main Citigroup Buy → Buy $20
2024-08-06 main Barclays Overweight → Overweight $17
2024-08-06 reit RBC Capital Outperform → Outperform $17
News
RSS: Latest SHC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-06 GTCR INVESTMENT XI L.L.C. Beneficial Owner of more than 10% of a Class of Security — 10,000,000 $15.27 $152,700,000
2026-03-06 WARBURG PINCUS & CO Beneficial Owner of more than 10% of a Class of Security — 15,000,000 $15.27 $229,050,000
2026-03-02 RUTZ MICHAEL PATRICK Officer — 45,223 $0.00 $0
2026-03-02 PETRAS MICHAEL B. JR. Chief Executive Officer — 240,248 $0.00 $0
2026-03-02 LYONS JONATHAN M Chief Financial Officer — 59,355 $0.00 $0
2026-03-02 RUTZ MICHAEL PATRICK Officer — 14,573 — —
2026-03-02 DIMITRIEF ALEXANDER General Counsel — 16,816 — —
2026-03-02 PETRAS MICHAEL B. JR. Chief Executive Officer — 89,686 — —
2026-03-02 LYONS JONATHAN M Chief Financial Officer — 17,937 — —
2025-12-08 PETRAS MICHAEL B. JR. Chief Executive Officer — 750,000 $16.45 $12,337,500
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,163.62
+5.74%
1,100.44
+4.88%
1,049.29
+4.54%
1,003.69
Operating Revenue
1,163.62
+5.74%
1,100.44
+4.88%
1,049.29
+4.54%
1,003.69
Cost Of Revenue
518.08
+4.00%
498.15
+5.51%
472.13
+5.70%
446.68
Reconciled Cost Of Revenue
412.12
+3.93%
396.55
+4.91%
378.00
+3.83%
364.07
Gross Profit
645.53
+7.18%
602.29
+4.36%
577.16
+3.62%
557.00
Operating Expense
283.50
-6.95%
304.67
+1.40%
300.47
-2.65%
308.65
Selling General And Administration
252.76
+4.18%
242.63
+2.52%
236.67
-3.68%
245.71
Total Expenses
801.58
-0.15%
802.82
+3.91%
772.60
+2.28%
755.34
Operating Income
362.03
+21.64%
297.63
+7.57%
276.69
+11.41%
248.35
Total Operating Income As Reported
—
297.63
+7.57%
276.69
+11.41%
248.35
EBITDA
439.93
-0.51%
442.20
+8.69%
406.83
+2436.36%
-17.41
Normalized EBITDA
507.29
+8.73%
466.57
+5.56%
441.99
+10.40%
400.35
Reconciled Depreciation
136.71
-16.46%
163.64
+3.62%
157.93
+8.50%
145.55
EBIT
303.23
+8.85%
278.56
+11.92%
248.91
+252.73%
-162.97
Total Unusual Items
-67.35
-176.41%
-24.37
+30.69%
-35.16
+91.58%
-417.76
Total Unusual Items Excluding Goodwill
-67.35
-176.41%
-24.37
+30.69%
-35.16
+91.58%
-417.76
Special Income Charges
-66.41
-174.76%
-24.17
+30.95%
-35.00
+91.62%
-417.61
Other Special Charges
66.41
+174.76%
24.17
-30.95%
35.00
-91.42%
408.00
Impairment Of Capital Assets
—
—
—
—
Write Off
—
0.00
0.00
-100.00%
9.61
Net Income
77.95
+75.57%
44.40
-13.58%
51.38
+122.00%
-233.57
Pretax Income
147.51
+29.53%
113.87
+7.40%
106.03
+143.61%
-243.11
Net Non Operating Interest Income Expense
-155.72
+5.45%
-164.69
-15.27%
-142.88
-78.28%
-80.14
Interest Expense Non Operating
155.72
-5.45%
164.69
+15.27%
142.88
+78.28%
80.14
Net Interest Income
-155.72
+5.45%
-164.69
-15.27%
-142.88
-78.28%
-80.14
Interest Expense
155.72
-5.45%
164.69
+15.27%
142.88
+78.28%
80.14
Other Income Expense
-58.81
-208.51%
-19.06
+31.40%
-27.79
+93.24%
-411.32
Other Non Operating Income Expenses
8.55
+61.06%
5.31
-28.02%
7.37
+14.45%
6.44
Gain On Sale Of Security
-0.95
-375.88%
-0.20
-25.16%
-0.16
-9.66%
-0.14
Tax Provision
69.56
+0.12%
69.48
+27.13%
54.65
+672.80%
-9.54
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+435.10%
0.00
Tax Effect Of Unusual Items
-14.14
-176.41%
-5.12
+30.69%
-7.38
+54.97%
-16.40
Net Income Including Noncontrolling Interests
77.95
+75.57%
44.40
-13.58%
51.38
+122.00%
-233.57
Net Income From Continuing Operation Net Minority Interest
77.95
+75.57%
44.40
-13.58%
51.38
+122.00%
-233.57
Net Income From Continuing And Discontinued Operation
77.95
+75.57%
44.40
-13.58%
51.38
+122.00%
-233.57
Net Income Continuous Operations
77.95
+75.57%
44.40
-13.58%
51.38
+122.00%
-233.57
Minority Interests
—
—
0.00
0.00
Normalized Income
131.16
+106.07%
63.65
-19.59%
79.15
-52.83%
167.79
Net Income Common Stockholders
77.95
+75.57%
44.40
-13.58%
51.38
+122.00%
-233.57
Diluted EPS
0.27
+68.75%
0.16
-11.11%
0.18
+121.69%
-0.83
Basic EPS
0.27
+68.75%
0.16
-11.11%
0.18
+121.69%
-0.83
Basic Average Shares
283.96
+0.41%
282.78
+0.63%
281.01
+0.33%
280.10
Diluted Average Shares
286.42
+0.53%
284.91
+0.59%
283.22
+1.12%
280.10
Diluted NI Availto Com Stockholders
77.95
+75.57%
44.40
-13.58%
51.38
+122.00%
-233.57
Amortization
30.74
-50.45%
62.04
-2.76%
63.80
+1.36%
62.94
Amortization Of Intangibles Income Statement
30.74
-50.45%
62.04
-2.76%
63.80
+1.36%
62.94
Depreciation Amortization Depletion Income Statement
30.74
-50.45%
62.04
-2.76%
63.80
+1.36%
62.94
Depreciation And Amortization In Income Statement
30.74
-50.45%
62.04
-2.76%
63.80
+1.36%
62.94
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
3,263.19
+6.24%
3,071.65
-1.88%
3,130.42
+0.41%
3,117.70
Current Assets
613.41
+16.61%
526.04
-5.60%
557.24
-13.61%
645.01
Cash Cash Equivalents And Short Term Investments
344.62
+24.30%
277.24
-6.47%
296.41
-25.00%
395.21
Cash And Cash Equivalents
344.62
+24.30%
277.24
-6.47%
296.41
-25.00%
395.21
Receivables
176.27
+6.31%
165.81
-5.53%
175.52
+12.72%
155.72
Accounts Receivable
139.33
-0.71%
140.33
-4.99%
147.70
+24.66%
118.48
Gross Accounts Receivable
142.30
-0.39%
142.86
-6.25%
152.38
+26.62%
120.35
Allowance For Doubtful Accounts Receivable
-2.97
-17.22%
-2.53
+46.00%
-4.69
-150.61%
-1.87
Other Receivables
24.41
+60.45%
15.21
-14.46%
17.79
-24.32%
23.50
Taxes Receivable
12.53
+21.98%
10.27
+2.31%
10.04
-26.91%
13.73
Inventory
54.38
+10.61%
49.16
+1.74%
48.32
+30.07%
37.15
Raw Materials
45.57
+7.45%
42.41
-2.31%
43.41
+19.25%
36.40
Work In Process
2.44
+162.22%
0.93
+97.24%
0.47
-19.35%
0.58
Finished Goods
6.62
+9.65%
6.04
+29.31%
4.67
+1592.03%
0.28
Prepaid Assets
17.09
-0.92%
17.24
+7.15%
16.09
-60.14%
40.38
Restricted Cash
1.83
+13.06%
1.62
-69.07%
5.25
+385.83%
1.08
Hedging Assets Current
1.16
-56.79%
2.69
+119.51%
1.23
-54.98%
2.72
Other Current Assets
18.07
+47.22%
12.27
-15.00%
14.44
+13.17%
12.76
Total Non Current Assets
2,649.78
+4.09%
2,545.61
-1.07%
2,573.18
+4.06%
2,472.70
Net PPE
1,163.96
+9.35%
1,064.44
+9.63%
970.95
+21.22%
801.01
Gross PPE
1,835.82
+12.84%
1,626.86
+10.24%
1,475.73
+19.02%
1,239.90
Accumulated Depreciation
-671.86
-19.46%
-562.41
-11.42%
-504.78
-15.01%
-438.90
Properties
0.00
0.00
0.00
0.00
Land And Improvements
470.90
+12.65%
418.04
+21.06%
345.31
+8.61%
317.93
Machinery Furniture Equipment
935.36
+13.31%
825.45
+7.18%
770.19
+22.21%
630.21
Construction In Progress
259.92
+3.79%
250.42
+1.38%
247.02
+27.57%
193.64
Other Properties
41.32
+18.33%
34.92
+14.01%
30.63
-0.35%
30.74
Leases
128.31
+30.89%
98.03
+18.70%
82.58
+22.55%
67.39
Goodwill And Other Intangible Assets
1,391.46
-0.52%
1,398.73
-8.43%
1,527.51
-4.11%
1,593.03
Goodwill
1,103.23
+2.05%
1,081.07
-2.71%
1,111.19
+0.86%
1,101.77
Other Intangible Assets
288.23
-9.26%
317.65
-23.70%
416.32
-15.26%
491.26
Investments And Advances
—
—
—
0.00
Long Term Equity Investment
—
—
—
0.00
Non Current Deferred Assets
3.85
+34.49%
2.87
-42.62%
4.99
+21.75%
4.10
Non Current Deferred Taxes Assets
3.85
+34.49%
2.87
-42.62%
4.99
+21.75%
4.10
Other Non Current Assets
36.69
-0.97%
37.05
-10.16%
41.24
+5.79%
38.98
Total Liabilities Net Minority Interest
2,657.16
-0.36%
2,666.74
-0.74%
2,686.69
-2.92%
2,767.47
Current Liabilities
249.58
+30.67%
191.00
-17.19%
230.65
-70.86%
791.57
Payables And Accrued Expenses
128.98
+15.15%
112.00
-30.32%
160.73
-69.67%
529.92
Payables
86.94
+30.58%
66.58
-14.20%
77.60
-6.03%
82.57
Accounts Payable
77.96
+41.50%
55.10
-22.44%
71.04
-4.18%
74.14
Current Accrued Expenses
42.03
-7.46%
45.42
-45.36%
83.13
-81.42%
447.34
Employee Benefits
8.12
+3.31%
7.86
-6.83%
8.44
+6.69%
7.91
Pensionand Other Post Retirement Benefit Plans Current
43.54
+17.63%
37.02
+5.65%
35.04
+6.38%
32.94
Total Tax Payable
8.98
-21.79%
11.48
+75.11%
6.56
-22.26%
8.43
Income Tax Payable
5.69
-24.69%
7.56
+82.14%
4.15
-29.27%
5.87
Current Debt And Capital Lease Obligation
23.19
+1.80%
22.78
+16.82%
19.50
-90.55%
206.40
Current Debt
13.97
-5.61%
14.80
+208.59%
4.80
-97.57%
197.12
Other Current Borrowings
13.97
-5.61%
14.80
+208.59%
4.80
-97.57%
197.12
Current Capital Lease Obligation
9.22
+15.55%
7.98
-45.74%
14.71
+58.53%
9.28
Current Deferred Liabilities
18.00
+19.20%
15.10
+11.92%
13.49
+11.14%
12.14
Current Deferred Revenue
18.00
+19.20%
15.10
+11.92%
13.49
+11.14%
12.14
Other Current Liabilities
1.87
-54.32%
4.10
+889.86%
0.41
-88.20%
3.51
Total Non Current Liabilities Net Minority Interest
2,407.57
-2.75%
2,475.74
+0.80%
2,456.03
+24.30%
1,975.90
Long Term Debt And Capital Lease Obligation
2,250.46
-3.32%
2,327.85
+0.88%
2,307.55
+26.40%
1,825.65
Long Term Debt
2,126.72
-3.69%
2,208.10
-0.70%
2,223.67
+27.28%
1,747.12
Long Term Capital Lease Obligation
123.74
+3.33%
119.75
+42.76%
83.88
+6.81%
78.53
Long Term Provisions
53.50
+8.47%
49.32
+2.87%
47.94
+12.58%
42.59
Defined Pension Benefit
53.82
+26.56%
42.52
+49.30%
28.48
-19.93%
35.57
Non Current Pension And Other Postretirement Benefit Plans
8.12
+3.31%
7.86
-6.83%
8.44
+6.69%
7.91
Non Current Deferred Liabilities
88.13
+2.14%
86.28
+3.69%
83.22
-4.27%
86.93
Non Current Deferred Revenue
17.06
+1.63%
16.78
-10.54%
18.76
-0.74%
18.90
Non Current Deferred Taxes Liabilities
71.08
+2.27%
69.50
+7.83%
64.45
-5.25%
68.02
Other Non Current Liabilities
7.36
+66.59%
4.42
-50.24%
8.88
-30.80%
12.83
Preferred Securities Outside Stock Equity
—
—
—
—
Stockholders Equity
606.03
+49.67%
404.91
-8.75%
443.73
+26.69%
350.24
Common Stock Equity
606.03
+49.67%
404.91
-8.75%
443.73
+26.69%
350.24
Capital Stock
2.86
+0.00%
2.86
+0.00%
2.86
+0.00%
2.86
Common Stock
2.86
+0.00%
2.86
+0.00%
2.86
+0.00%
2.86
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
286.04
+0.00%
286.04
+0.00%
286.04
+0.00%
286.04
Ordinary Shares Number
284.37
+0.32%
283.47
+0.22%
282.83
+0.14%
282.42
Treasury Shares Number
1.67
-35.20%
2.57
-19.83%
3.21
-11.31%
3.62
Additional Paid In Capital
1,262.12
+1.47%
1,243.78
+2.35%
1,215.18
+2.15%
1,189.62
Retained Earnings
-532.09
+12.78%
-610.04
+6.78%
-654.44
+7.28%
-705.82
Gains Losses Not Affecting Retained Earnings
-109.84
+47.26%
-208.25
-124.69%
-92.68
+13.10%
-106.65
Treasury Stock
17.01
-27.40%
23.43
-13.79%
27.18
-8.71%
29.77
Minority Interest
—
—
0.00
0.00
Other Equity Adjustments
-109.84
+47.26%
-208.25
-124.69%
-92.68
+13.10%
-106.65
Total Equity Gross Minority Interest
606.03
+49.67%
404.91
-8.75%
443.73
+26.69%
350.24
Total Capitalization
2,732.76
+4.58%
2,613.01
-2.04%
2,667.41
+27.18%
2,097.35
Working Capital
363.83
+8.59%
335.04
+2.59%
326.59
+322.84%
-146.56
Invested Capital
2,746.73
+4.53%
2,627.81
-1.66%
2,672.20
+16.46%
2,294.47
Total Debt
2,273.65
-3.27%
2,350.63
+1.01%
2,327.06
+14.52%
2,032.04
Net Debt
1,796.08
-7.69%
1,945.66
+0.70%
1,932.06
+24.73%
1,549.02
Capital Lease Obligations
132.96
+4.09%
127.73
+29.56%
98.58
+12.27%
87.81
Net Tangible Assets
-785.42
+20.97%
-993.82
+8.30%
-1,083.77
+12.80%
-1,242.80
Tangible Book Value
-785.42
+20.97%
-993.82
+8.30%
-1,083.77
+12.80%
-1,242.80
Current Provisions
34.00
—
1.48
-77.82%
6.67
Interest Payable
20.54
-18.87%
25.32
-5.10%
26.68
+14.55%
23.29
Inventories Adjustments Allowances
-0.25
-15.60%
-0.22
+7.63%
-0.24
-101.71%
-0.12
Investments In Other Ventures Under Equity Method
—
—
—
0.00
Investmentsin Associatesat Cost
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
287.19
+28.12%
224.16
+251.74%
-147.73
-153.15%
277.96
Cash Flow From Continuing Operating Activities
287.19
+28.12%
224.16
+251.74%
-147.73
-153.15%
277.96
Net Income From Continuing Operations
77.95
+75.57%
44.40
-13.58%
51.38
+122.00%
-233.57
Depreciation Amortization Depletion
136.71
-16.46%
163.64
+3.62%
157.93
+8.50%
145.55
Depreciation
94.91
+12.64%
84.26
+10.03%
76.58
+19.65%
64.00
Amortization Cash Flow
41.80
-47.34%
79.38
-2.42%
81.35
-0.25%
81.55
Depreciation And Amortization
136.71
-16.46%
163.64
+3.62%
157.93
+8.50%
145.55
Amortization Of Intangibles
41.80
-47.34%
79.38
-2.42%
81.35
-0.25%
81.55
Other Non Cash Items
4.94
-82.77%
28.68
+366.67%
6.14
+593.57%
0.89
Stock Based Compensation
30.88
-16.04%
36.78
+14.08%
32.24
+51.99%
21.21
Asset Impairment Charge
—
0.00
0.00
-100.00%
9.61
Deferred Tax
0.02
-99.77%
9.43
+173.50%
3.45
+104.66%
-73.96
Deferred Income Tax
0.02
-99.77%
9.43
+173.50%
3.45
+104.66%
-73.96
Operating Gains Losses
8.65
+153.67%
-16.12
-464.80%
4.42
+538.93%
-1.01
Gain Loss On Investment Securities
-0.86
-139.00%
2.21
+235.19%
-1.64
-154.99%
2.98
Net Foreign Currency Exchange Gain Loss
9.52
+151.90%
-18.34
-402.74%
6.06
+252.03%
-3.98
Change In Working Capital
28.04
+165.78%
-42.63
+89.43%
-403.29
-198.55%
409.23
Change In Receivables
7.15
+222.70%
2.22
+110.20%
-21.72
-73.03%
-12.55
Changes In Account Receivables
7.15
+222.70%
2.22
+110.20%
-21.72
-73.03%
-12.55
Change In Inventory
-2.38
+49.99%
-4.75
+52.34%
-9.97
-169.05%
14.44
Change In Payables And Accrued Expense
7.13
+1416.17%
0.47
+125.64%
-1.83
-108.45%
21.70
Change In Accrued Expense
1.94
-72.72%
7.11
+103.26%
3.50
-83.01%
20.59
Change In Payable
5.18
+178.04%
-6.64
-24.58%
-5.33
-581.75%
1.11
Change In Account Payable
5.18
+178.04%
-6.64
-24.58%
-5.33
-581.75%
1.11
Change In Other Working Capital
28.54
+185.11%
-33.53
+90.98%
-371.79
-193.96%
395.67
Change In Other Current Assets
-12.69
-291.18%
-3.24
-186.16%
3.77
+136.18%
-10.40
Change In Other Current Liabilities
0.29
+107.78%
-3.79
-118.87%
-1.73
-552.48%
0.38
Investing Cash Flow
-135.14
+24.50%
-179.00
+16.71%
-214.91
-18.15%
-181.90
Cash Flow From Continuing Investing Activities
-135.14
+24.50%
-179.00
+16.71%
-214.91
-18.15%
-181.90
Net PPE Purchase And Sale
-138.02
+22.93%
-179.07
+16.70%
-214.97
-17.87%
-182.38
Purchase Of PPE
-138.02
+22.93%
-179.07
+16.70%
-214.97
-17.87%
-182.38
Capital Expenditure
-138.02
+22.93%
-179.07
+16.70%
-214.97
-17.87%
-182.38
Net Business Purchase And Sale
—
0.00
0.00
-100.00%
0.45
Purchase Of Business
—
—
0.00
0.00
Net Other Investing Changes
2.87
+3783.78%
0.07
+7.25%
0.07
+115.63%
0.03
Financing Cash Flow
-100.53
-98.83%
-50.56
-119.01%
265.96
+34.49%
197.76
Cash Flow From Continuing Financing Activities
-100.53
-98.83%
-50.56
-119.01%
265.96
+34.49%
197.76
Net Issuance Payments Of Debt
-86.10
-632.24%
-11.76
-103.95%
297.50
+48.75%
200.00
Issuance Of Debt
0.00
-100.00%
2,259.35
+351.87%
500.00
+150.00%
200.00
Repayment Of Debt
-86.10
+96.21%
-2,271.11
-1021.54%
-202.50
0.00
Long Term Debt Issuance
0.00
-100.00%
2,259.35
+351.87%
500.00
+150.00%
200.00
Long Term Debt Payments
0.00
+100.00%
-6.74
0.00
0.00
Net Long Term Debt Issuance
0.00
-100.00%
2,252.61
+350.52%
500.00
+150.00%
200.00
Short Term Debt Issuance
—
—
—
200.00
Short Term Debt Payments
-86.10
+96.20%
-2,264.37
-1018.21%
-202.50
0.00
Net Short Term Debt Issuance
-86.10
+96.20%
-2,264.37
-1018.21%
-202.50
0.00
Net Common Stock Issuance
—
-4.43
-8.29%
-4.09
0.00
Common Stock Payments
—
-4.43
-8.29%
-4.09
0.00
Cash Dividends Paid
—
—
—
—
Repurchase Of Capital Stock
—
-4.43
-8.29%
-4.09
0.00
Proceeds From Stock Option Exercised
-6.57
-48.33%
-4.43
-8.29%
-4.09
-940.46%
-0.39
Net Other Financing Charges
-7.86
+77.13%
-34.38
-25.23%
-27.45
-1387.11%
-1.85
Changes In Cash
51.52
+1054.73%
-5.40
+94.42%
-96.68
-132.90%
293.83
Effect Of Exchange Rate Changes
16.07
+192.42%
-17.39
-953.02%
2.04
+145.76%
-4.46
Beginning Cash Position
278.87
-7.55%
301.65
-23.88%
396.29
+270.63%
106.92
End Cash Position
346.46
+24.24%
278.87
-7.55%
301.65
-23.88%
396.29
Free Cash Flow
149.18
+230.81%
45.09
+112.43%
-362.71
-479.47%
95.58
Interest Paid Supplemental Data
164.01
-8.84%
179.92
+3.50%
173.84
+129.19%
75.85
Income Tax Paid Supplemental Data
60.87
-7.53%
65.83
+31.11%
50.21
-33.49%
75.50
Common Stock Issuance
—
—
—
0.00
Issuance Of Capital Stock
—
—
—
0.00
Sale Of Business
—
0.00
0.00
-100.00%
0.45
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category